Download presentation
Presentation is loading. Please wait.
Published byAllan Shaw Modified over 6 years ago
1
A 46 year old man with reduced gfr and nephrotic syndrome
Knut Aasarød Dept. of Nephrology Trondheim University Hospital
2
Previously mostly healthy man.
Slight depressive symptoms, a period of high alcohol consumption. Both parents hypertensive A history of edema in 1990, resolved May 2007 at his GP: s-creatinine 111 µmol/l No actions taken Knut Aasarød
3
2007 – 2008 generally reduced well-being
Shortnes of breath on climbing a few stairs Frontal headache, dizziness On admission Oct. 2008 BP 230/130 mmHg, HR 112 sr Edema around both ankles Ecco-cardiography: LVH, reduced speed of relaxation Retinal us: hypertensive retinopathy grade 2 Knut Aasarød
4
BP Hgb Trc s-Creatinine s-albumin ANA/subgroups ANCA/aGBM C3 and C4
Oct 2008 Kidney biopsy April 2009 April – Sept 2009 Nov 2009 BP 230/130 160/103 Cs+ cyclo phosphamide 128/90 Hgb 12,1 g/dl 11,6 g/dl Trc 291 s-Creatinine 200 µmol/l 253µmol/l 255µmol/l s-albumin 30 g/l 32 g/l 39 ANA/subgroups Neg ANCA/aGBM C3 and C4 N Hep B/C HIV Cryoglob. s-κ/λ ratio s-ELFO Urin dipstick Alb4+/blood 2+ U-alb/creat. 512 mg/mmol 386 mg/mmol 12,9 mg/mmol Knut Aasarød
5
BP Hgb Trc s-Creatinine s-albumin Urin dipstick U-alb/creat. Aug. 2011
Sept. 2011 Oct 2012 Feb. 2015 Hemodialysis From April 2015 BP 129/85 131/92 CyA + CS Kidney biopsy. 144/98 Hgb 12,0 g/dl 11,6 g/dl Trc 170 s-Creatinine 154 µmol/l 221µmol/l 401µmol/l s-albumin 36 g/l 39 g/l Urin dipstick Alb2+/bl. 0 Alb2+/bl. 3+ Alb 5+/Bl 5+ U-alb/creat. 154 mg/mmol 279 mg/mmol 574 mg/mmol About 2 years later, creatinine nadir in August 2011, but albuminuria has started to rise Knut Aasarød
6
Received a LD transplant from a 25 year old daughter
7 th January 2016 Received a LD transplant from a 25 year old daughter 0 A / HLA / CMV CMV+ Prednisolon/tacrolimus/MMF s-creatinine 120 µmol/l 6 weeks post TX: creatinine 150 µmol/ + albuminuria TX biopsy Knut Aasarød
7
Post transplant BP Hgb Trc s-Creatinine s-albumin ANA/subgroups
March. 2016 Nov. 2016 April 2017 Aug. 2017 BP 145/96 137/82 TX biopsy 123/80 Hgb 16,5 g/dl 16,2 g/dl Trc s-Creatinine 120 µmol/l 97 µmol/l 103 µmol/l s-albumin 37 g/l 38 g/l 34 g/l ANA/subgroups Neg C3 and C4 N Hep B/C HIV Cryoglob. s-κ/λ ratio s-ELFO Urin dipstick Alb3+/bl. 5+ Alb 3+/Bl 5+ U-alb/creat. 104 mg/mmol 115 mg/mmol 228 mg/mmol Knut Aasarød
8
Concerns regarding this patient
Was it an immune complex disease? Use of living related donor? What now? Rituximab? PE? Cyclophosphamide? Knut Aasarød
9
MPGN – recurrence after kidney transplantation
Independent variable Hazard ratio (CI) P-value Age at transplantation 1.019 (0.937–1.018) 0.65 Gender (Male) 1.00 (0.118–8.420) 1 Race (Caucasian) 1.5 (0.120–18.411) 0.1 Allograft source (Living related) 10.19 (0.866–12.96) 0.045 Duration of dialysis 0.951 (0.775–1.167) 0.612 Preemptive transplantation 6.322 (1.455–12.411) 0.018 Previous failed transplantation 0.833 (0.098–7.026) 0.86 DGF (In deceased donor) 1.21 (0.158–9.508) 0.83 Development of rejection 3.148 (0.854–9.546) 0.25 Use of ACEi/ARB 1.312 (0.587–5.847) 0.658 Low complement level 5.522 (1.632–18.679) 0.006 Evidence of monoclonal gammopathy 5.606 (1.522–20.642) 0.010 Alasfar S et al. BMC Nephrology 2016 Knut Aasarød
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.